Celyad starting this month
EPITHINK: Epigenetic Drug Treatment and Therapeutic Immunotherapy With NKR-2 (EPITHINK)
ClinicalTrials.gov Identifier: NCT03612739
Last Update Posted : August 2, 2018
Estimated Study Start Date : August 2018
Estimated Primary Completion Date : May 2019
Celyad starting this month
EPITHINK: Epigenetic Drug Treatment and Therapeutic Immunotherapy With NKR-2 (EPITHINK)
ClinicalTrials.gov Identifier: NCT03612739
Last Update Posted : August 2, 2018
Estimated Study Start Date : August 2018
Estimated Primary Completion Date : May 2019